Fig. 1
Association of cholesterol remnants levels to global longitudinal strain and longitudinal displacement in patients with type 2 diabetes and in patients with type 2 diabetes receiving statin therapy. The upper curves depict the predicted value with 95 % confidence interval of GLS and longitudinal displacement for increasing levels of cholesterol remnants on the original scale for both all patients and patients receiving statin therapy. The lower histograms are the distribution of cholesterol remnants in all patients and patients receiving statin therapy. Cholesterol remnants were calculated by total-cholesterol − HDL-cholesterol − LDL-cholesterol